Iterum Therapeutics
ITRMF · NASDAQ
$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Who owns ITRMF
Largest institutional holders, from their latest 13F filings
The 9 largest institutions hold 1.3% of ITRMF’s shares.
- Abante Asesores Gestión, S.G.I.I.C., S.A.0.5%
- Dunne (Michael W)0.5%
- Fishman (Corey N)0.3%
- Hecht (Beth P)0.0%
- Next 5 largest institutions0.1%
- All other shareholders98.7%
| Holder | Shares | % of shares |
|---|---|---|
| Abante Asesores Gestión, S.G.I.I.C., S.A. | 264.77K | 0.50% |
| Dunne (Michael W) | 241.00K | 0.45% |
| Fishman (Corey N) | 137.06K | 0.26% |
| Hecht (Beth P) | 18.84K | 0.04% |
| Barclays Capital Inc. | 10.79K | 0.02% |
| Puttagunta (Sailaja) | 10.37K | 0.02% |
| Matthews (Judith M) | 8.13K | 0.02% |
| Kelly (David George) | 2.47K | 0.00% |
| Cypress Capital Management, LLC (WY) | 66 | 0.00% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Abante Quant Value, FI | 264.77K | 0.50% |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.74M
- Days to cover
- 999.99
- % of shares outstanding
- 3.26%
- Average daily volume
- —
- Change since last report
- +0.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.